CHA2DS2-VASc and HAS-BLED are clinical scoring tools used in atrial fibrillation to estimate stroke risk and bleeding risk. This cheat sheet helps college-level medical science students compare the two scores, remember each point category, and understand how clinicians balance benefits and harms. These tools support structured thinking, but they do not replace individualized clinical judgment or current guidelines.
CHA2DS2-VASc estimates thromboembolic stroke risk using congestive heart failure, hypertension, age, diabetes, stroke history, vascular disease, sex category, and age thresholds. HAS-BLED estimates major bleeding risk using hypertension, abnormal renal or liver function, stroke history, bleeding history, labile INR, older age, and drugs or alcohol. In practice, high bleeding risk should usually prompt correction of modifiable risk factors rather than automatic avoidance of anticoagulation.
Key Facts
- CHA2DS2-VASc assigns 1 point each for congestive heart failure, hypertension, diabetes mellitus, vascular disease, age 65 to 74 years, and female sex category.
- CHA2DS2-VASc assigns 2 points each for age 75 years or older and prior stroke, transient ischemic attack, or thromboembolism.
- The maximum CHA2DS2-VASc score is 9, and higher scores indicate greater estimated annual stroke risk in atrial fibrillation.
- HAS-BLED assigns 1 point each for hypertension, abnormal renal function, abnormal liver function, prior stroke, prior bleeding, labile INR, age over 65 years, drugs increasing bleeding risk, and alcohol use.
- The maximum HAS-BLED score is 9 because abnormal renal and liver function can each score separately, and drugs and alcohol can each score separately.
- A HAS-BLED score of 3 or more indicates high bleeding risk and the need for closer monitoring and correction of modifiable risk factors.
- Common modifiable HAS-BLED factors include uncontrolled blood pressure, interacting medications such as NSAIDs or antiplatelets, excess alcohol use, and unstable INR control.
- Anticoagulation decisions compare estimated stroke prevention benefit against bleeding risk, patient values, contraindications, renal function, and guideline recommendations.
Vocabulary
- Atrial fibrillation
- An irregular heart rhythm that can cause blood stasis in the atria and increase the risk of clot formation and stroke.
- CHA2DS2-VASc
- A clinical score used to estimate stroke risk in patients with nonvalvular atrial fibrillation.
- HAS-BLED
- A clinical score used to estimate the risk of major bleeding in patients considered for or receiving anticoagulation.
- Anticoagulation
- Treatment that reduces blood clot formation, commonly using medications such as warfarin or direct oral anticoagulants.
- Labile INR
- Unstable or poorly controlled international normalized ratio values in a patient taking warfarin.
- Thromboembolism
- A blood clot that forms in one location and travels through the bloodstream to block a vessel elsewhere.
Common Mistakes to Avoid
- Counting female sex as an automatic reason for anticoagulation, which is wrong because sex category modifies risk and must be interpreted with the full CHA2DS2-VASc score.
- Giving only 1 point for age 75 years or older on CHA2DS2-VASc, which is wrong because age 75 or older is worth 2 points.
- Using HAS-BLED to deny anticoagulation automatically, which is wrong because a high score usually signals the need to reduce bleeding risks and monitor more closely.
- Forgetting that abnormal renal function and abnormal liver function can each add 1 HAS-BLED point, which underestimates bleeding risk when both are present.
- Ignoring medication and alcohol factors in HAS-BLED, which is wrong because NSAIDs, antiplatelet drugs, and excess alcohol can substantially increase bleeding risk.
Practice Questions
- 1 Calculate the CHA2DS2-VASc score for a 78-year-old man with hypertension, diabetes, and a prior transient ischemic attack.
- 2 Calculate the HAS-BLED score for a 70-year-old patient with uncontrolled hypertension, prior bleeding, labile INR, and regular NSAID use.
- 3 A 66-year-old woman with atrial fibrillation has hypertension and vascular disease but no prior stroke, diabetes, or heart failure. What is her CHA2DS2-VASc score?
- 4 A patient has both high CHA2DS2-VASc and high HAS-BLED scores. Explain why this does not automatically mean anticoagulation should be avoided.